Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

CNBX Pharmaceuticals (CNBX) Gross Margin (2016 - 2024)

CNBX Pharmaceuticals (CNBX) has disclosed Gross Margin for 5 consecutive years, with 84.69% as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Gross Margin changed N/A year-over-year to 84.69%, compared with a TTM value of 0.83% through Feb 2024, down 61364.0%, and an annual FY2024 reading of 58.81%, down 2911.0% over the prior year.
  • Gross Margin was 84.69% for Q1 2024 at CNBX Pharmaceuticals, up from 1274.97% in the prior quarter.
  • Across five years, Gross Margin topped out at 84.69% in Q1 2024 and bottomed at 84.69% in Q1 2024.